Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study
| Autor: | Alicia Dawdani, Thomas R. Radomski, Carolyn T. Thorpe, Walid F. Gellad, Aimee N. Pickering, Megan Hamm, Joseph T. Hanlon |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Value (ethics)
Male medicine.medical_specialty Health Knowledge Attitudes Practice Patients Psychological intervention 030204 cardiovascular system & hematology Article 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Deprescriptions medicine Humans 030212 general & internal medicine Adverse effect Qualitative Research Aged Polypharmacy business.industry Focus Groups Focus group Caregivers Family medicine Quality of Life Female Independent Living Geriatrics and Gerontology Deprescribing business Qualitative research |
| Zdroj: | J Am Geriatr Soc |
| Popis: | Objectives Shared decision making is essential to deprescribing unnecessary or harmful medications in older adults, yet patients' and caregivers' perspectives on medication value and how this affects their willingness to discontinue a medication are poorly understood. We sought to identify the most significant factors that impact the perceived value of a medication from the perspective of patients and caregivers. Design Qualitative study using focus groups conducted in September and October 2018. Setting Participants from the Pepper Geriatric Research Registry (patients) and the Pitt+Me Registry (caregivers) maintained by the University of Pittsburgh. Participants Six focus groups of community-dwelling adults aged 65 years or older, or their caregivers, prescribed five or more medications in the preceding 12 months. Measurements We sought to identify (1) general views on medication value and what makes medication worth taking; (2) how specific features such as cost or side effects impact perceived value; and (3) reactions to clinical scenarios related to deprescribing. Results We identified four themes. Perceived effectiveness was the primary factor that caused participants to consider a medication to be of high value. Participants considered a medication to be of low value if it adversely affected quality of life. Participants also cited cost when determining value, especially if it resulted in material sacrifices. Participants valued medications prescribed by providers with whom they had good relationships rather than valuing level of training. When presented with clinical scenarios, participants ably weighed these factors when determining the value of a medication and indicated whether they would adhere to a deprescribing recommendation. Conclusion We identified that perceived effectiveness, adverse effects on quality of life, cost, and a strong relationship with the prescriber influenced patients' and caregivers' views on medication value. These findings will enable prescribers to engage older patients in shared decision making when deprescribing unnecessary medications and will allow health systems to incorporate patient-centered assessment of value into systems-based deprescribing interventions. J Am Geriatr Soc 68:746-753, 2020. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|